Incidence and survival trends for appendiceal mucinous adenocarcinoma: an analysis of 3237 patients in the Surveillance, Epidemiology, and End Results database

Future Oncol. 2019 Dec;15(34):3945-3961. doi: 10.2217/fon-2019-0229. Epub 2019 Nov 20.

Abstract

Aim: To characterize the epidemiology of appendiceal mucinous adenocarcinoma. Methods: Prognostic factors were evaluated with univariate and multivariate analyses. The results were used to generate a nomogram. Results: The incidence of appendiceal mucinous adenocarcinoma showed a significant upward trend. Multivariate Cox analysis identified 11 independent prognostic factors. The nomogram was based on independent risk factors that were significant in multivariate Cox analysis, and the concordance-index for overall survival and cancer-specific survival were 0.76 (95% CI: 0.71-0.79) and 0.74 (95% CI: 0.70-0.79), respectively. Conclusion: Advanced age, single relationship status, male sex, black race, the presence of distant and regional lymph node metastases, poor differentiation or lack of differentiation, advanced SEER extent of disease, cancer-directed surgery and chemotherapy were independently associated with prognosis.

Keywords: SEER program; appendiceal mucinous adenocarcinoma; cancer-specific survival; nomogram; overall survival.

MeSH terms

  • Adenocarcinoma, Mucinous / epidemiology*
  • Adenocarcinoma, Mucinous / pathology
  • Adenocarcinoma, Mucinous / therapy
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Appendectomy / statistics & numerical data
  • Appendiceal Neoplasms / epidemiology*
  • Appendiceal Neoplasms / pathology
  • Appendiceal Neoplasms / therapy
  • Child
  • Child, Preschool
  • Colectomy / statistics & numerical data
  • Female
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Kaplan-Meier Estimate
  • Lymphatic Metastasis / pathology
  • Lymphatic Metastasis / therapy
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Nomograms
  • Risk Factors
  • SEER Program / statistics & numerical data*
  • Sex Factors
  • Survival Rate
  • Young Adult

Substances

  • Antineoplastic Agents